Number of new molecular entities launched in the U.S. from 2003 to 2015

Number of new drugs launched in the U.S. 2003-2015 This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Loading statistic...
New MechanismOrphanExisting Mechanism
20031365
20041253
20051146
20061099
2007657
2008767
20098718
2010989
2011111210
20121288
201381711
201472018
2015141514
New MechanismOrphanExisting Mechanism
20031365
20041253
20051146
20061099
2007657
2008767
20098718
2010989
2011111210
20121288
201381711
201472018
2015141514
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Release date
April 2016
Region
United States
Survey time period
2003 to 2015
Supplementary notes
New Molecular Entity (NME): A novel molecular or biologic entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Clinical trials

All Information
in one Presentation

Clinical trials

Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
The most important statistics
  • Outlook
  • The consumer's view
The most important statistics
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

5 News

We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.